Arsani William - 13 Aug 2025 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Role: Director
Signature: /s/ Mustapha Parekh, Attorney-in-Fact
Issuer symbol: DSGN
Transactions as of: 13 Aug 2025
Net transactions value: -$2,953,792
Form type: 4
Filing time: 14 Aug 2025, 16:15:08 UTC
Previous filing: 12 Jun 2025
SEC: View on sec.gov

Quoteable Key Fact

"Arsani William filed Form 4 for Design Therapeutics, Inc. (DSGN) on 14 Aug 2025."

Quick Takeaways

This page summarizes Arsani William's Form 4 filing for Design Therapeutics, Inc. (DSGN).
2 reported transactions and 0 derivative rows are listed below.
Filing timestamp: 14 Aug 2025, 16:15.

What Changed

Previous filing in this sequence was filed on 12 Jun 2025.
Current net transaction value: -$2,953,792.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
William Arsani	Director	C/O DESIGN THERAPEUTICS, INC., 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD	/s/ Mustapha Parekh, Attorney-in-Fact	14 Aug 2025	0001848372

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DSGN	Common Stock	Sale	$1,811,250	-345,000	-12%	$5.25	2,655,000	13 Aug 2025	By Logos Global Master Fund LP	F1
transaction	DSGN	Common Stock	Sale	$1,142,542	-217,627	-18%	$5.25	1,000,000	13 Aug 2025	By Logos Opportunities Fund II LP	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Logos GP LLC ("Fund GP") is the general partner of Logos Global Master Fund LP (the "Fund"). The Reporting Person is the Managing Member of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F2	Logos Global Management LP is the investment advisor of private funds, including Logos Opportunities Fund II LP ("LOF II"). Logos Opportunities GP LLC ("GP I") is the general partner of LOF II. The Reporting Person is the Managing Member of GP I. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Content

Logos GP LLC ("Fund GP") is the general partner of Logos Global Master Fund LP (the "Fund"). The Reporting Person is the Managing Member of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Logos Global Management LP is the investment advisor of private funds, including Logos Opportunities Fund II LP ("LOF II"). Logos Opportunities GP LLC ("GP I") is the general partner of LOF II. The Reporting Person is the Managing Member of GP I. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.